[go: up one dir, main page]

TNSN90053A1 - Procede d'obtention de nouveaux derives alcoyles en 17/21 de la 19- nor progesterone - Google Patents

Procede d'obtention de nouveaux derives alcoyles en 17/21 de la 19- nor progesterone

Info

Publication number
TNSN90053A1
TNSN90053A1 TNTNSN90053A TNSN90053A TNSN90053A1 TN SN90053 A1 TNSN90053 A1 TN SN90053A1 TN TNSN90053 A TNTNSN90053 A TN TNSN90053A TN SN90053 A TNSN90053 A TN SN90053A TN SN90053 A1 TNSN90053 A1 TN SN90053A1
Authority
TN
Tunisia
Prior art keywords
progesterone
alkyl derivatives
obtaining new
carbon atoms
branched chain
Prior art date
Application number
TNTNSN90053A
Other languages
English (en)
Inventor
Claude Tchernatinsky
Nejib Mohamed Nasraoui
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of TNSN90053A1 publication Critical patent/TNSN90053A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L'INVENTION SE RAPPORTE AU DOMAINE DE LA CHIMIE ET PLUS PARTICULIEREMENT A CELUI DE LA CHIMIE THERAPEUTIQUE. ELLE A PARTICULIEREMENT POUR OBJET LES 6-METHYL 19-NOR PREGNA 4,6-DIENES 17α, ET EVENTUELLEMENT, 21- ALCOYLES DE FORMULE GENERALE I (I) DANS LAQUELLE R" ET R' IDENTIQUES OU DIFFERENTS REPRESENTENT DE L'HYDROGENE OU UN RADICAL ALCOYLE AYANT DE 1 A 3 ATOMES DE CARBONE EN CHAINE DROITE OU RAMIFIEE ET R1 REPRESENTE UN RADICAL ALCOYLE INFERIEUR AYANT DE 1 A 6 ATOMES DE CARBONE, EN CHAINE DROITE OU RAMIFIEE ELLE A EGALEMENT POUR OBJET UN PROCEDE D'OBTENTION DES COMPOSES DE FORMULE GENERALE I ET LEUR EMPLOI COMME PRINCIPES ACTIFS DE MEDICAMENTS.
TNTNSN90053A 1989-04-13 1990-04-13 Procede d'obtention de nouveaux derives alcoyles en 17/21 de la 19- nor progesterone TNSN90053A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8904910A FR2645864B1 (fr) 1989-04-13 1989-04-13 Nouveaux derives alcoyles en 17/21 de la 19-nor progesterone, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant

Publications (1)

Publication Number Publication Date
TNSN90053A1 true TNSN90053A1 (fr) 1991-03-05

Family

ID=9380699

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN90053A TNSN90053A1 (fr) 1989-04-13 1990-04-13 Procede d'obtention de nouveaux derives alcoyles en 17/21 de la 19- nor progesterone

Country Status (12)

Country Link
EP (1) EP0437552A1 (fr)
JP (1) JPH04500523A (fr)
KR (1) KR920700219A (fr)
AU (1) AU635739B2 (fr)
FI (1) FI906116A7 (fr)
FR (1) FR2645864B1 (fr)
HU (1) HU208152B (fr)
NO (1) NO174393C (fr)
OA (1) OA09632A (fr)
RU (1) RU1836379C (fr)
TN (1) TNSN90053A1 (fr)
WO (1) WO1990012027A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2675047B1 (fr) * 1991-04-09 1995-05-12 Theramex Nouvelles compositions pharmaceutiques anti-glaucomateuses et leur procede d'obtention.
WO1992022300A1 (fr) * 1991-06-18 1992-12-23 Laboratoire Theramex S.A. Compositions oculaires contenant des steroïdes et leur utilisation pour le traitement du glaucome
FR2679236B1 (fr) * 1991-07-18 1997-01-24 Theramex Nouveaux sterouides substitues en position 6, leurs procedes d'obtention et des compositions pharmaceutiques en renfermant.
HU231125B1 (hu) * 2016-12-16 2020-12-28 Richter Gedeon Nyrt. Ipari eljárás Nomegesztrol-acetát előállítására

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361744A (en) * 1962-07-18 1968-01-02 American Cyanamid Co Novel 17-hydrocarbon substituted progesterones, intermediates and methods of preparing the same
FR2077877B1 (fr) * 1970-02-20 1974-02-01 Roussel Uclaf
FR2552766B1 (fr) * 1983-10-04 1987-06-26 Theramex Nouveau procede de preparation de derives de la serie du 17 a-hydroxy 19-nor progesterone
AU624096B2 (en) * 1987-10-27 1992-06-04 Laboratoire Theramex S.A. Derivatives of 19-norprogesterone, their preparation and their use

Also Published As

Publication number Publication date
HU904373D0 (en) 1991-06-28
FR2645864B1 (fr) 1991-07-12
AU635739B2 (en) 1993-04-01
HU208152B (en) 1993-08-30
AU5552590A (en) 1990-11-05
KR920700219A (ko) 1992-02-19
EP0437552A1 (fr) 1991-07-24
RU1836379C (ru) 1993-08-23
FI906116A0 (fi) 1990-12-12
JPH04500523A (ja) 1992-01-30
NO905344D0 (no) 1990-12-11
OA09632A (fr) 1993-04-30
FR2645864A1 (fr) 1990-10-19
NO174393B (no) 1994-01-17
NO905344L (no) 1991-02-01
WO1990012027A1 (fr) 1990-10-18
FI906116A7 (fi) 1990-12-12
HUT56579A (en) 1991-09-30
NO174393C (no) 1994-04-27

Similar Documents

Publication Publication Date Title
PT82361A (fr) Procede de preparation de derives benzonaphtaleniques et leur application dans le domaines pharmaceutique et cosmetique
FR2360587A1 (fr) Nouveaux derives d'amino-alcoyl-furannes utiles comme medicaments
TNSN97127A1 (fr) Derives de benzylamine amido-substitues, leurs derives precurseurs de medicaments, leur procede de preparation, compositions pharmaceutiques les contenant et methode de traitement les utilisant
IL133585A0 (en) Soluble prodrugs of paclitaxel
FR2427320A2 (fr) Derives d'acides phenoxyalkylcarboxyliques et leur application en therapeutique
FR2421889A1 (fr) Nouveaux derives d'acide thiazolidinecarboxylique-4 utiles comme medicaments antihypertenseurs et procedes pour leur preparation
FR2397403A1 (fr) Nouveaux derives de 1-acyl 2-cyano-aziridine, procede pour leur preparation et compositions pharmaceutiques contenant ces composes
FR2404634A1 (fr) Composes de thiazole et compositions pharmaceutiques en contenant
TNSN88041A1 (fr) NOUVEAUX β-D-PHENYL THIOXYLOSIDES, LEUR PROCEDE DE PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2380285A1 (fr) Nouveaux derives insatures d'acides 7-acylamido-3-cephem-4-carboxyliques, utiles notamment comme agents antibacteriens, et leur procede de preparation
FR2354761A1 (fr) Acides n-aryl-anthraniliques, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits acides anthraniliques
KR900001693A (ko) 아자사이클릭 화합물, 이의 제조방법 및 이의 용도
TNSN90053A1 (fr) Procede d'obtention de nouveaux derives alcoyles en 17/21 de la 19- nor progesterone
FR2407928A1 (fr) Derives de quinazoline utiles comme medicaments antihypertenseurs et procede de leur preparation
FR2443471A1 (fr) Derives du type thiazolidine de la progesterone utiles notamment comme precurseurs de medicaments antiacne et antiseborrhee
FR2452483A1 (fr) Derives d'alcenylphenylmaleimides, leurs dimeres lineaires et leur procede de preparation
FR2446829A1 (fr) Derives de polymethylene disubstitues en alpha, omega, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2358388A1 (fr) Nouvelles 1,2,3,4-tetrahydro-4-imino-1-naphtylurees substituees, utiles notamment comme agents de croissance pour animaux, et leur procede de preparation
ES8707111A1 (es) Procedimiento para obtencion de un preparado farmaceutico para tratamiento terapeutico de enfermedades reumaticas.
FR2430232A1 (fr) Nouveaux acides arylaminobenzoiques utiles notamment comme agents hypoglycemiants
FR2422638A1 (fr) Nouveaux derives de 3,3-dichloro-2-azetidinone, utiles notamment comme agents anti-inflammatoires
FR2416013A1 (fr) Derives d'acide (-)-(cis)-1,2-epoxypropylphosphonique, leur preparation et compositions pharmaceutiques les contenant
FR2388789A1 (fr) Derives d'acide benzoique, leur procede de preparation et leur application therapeutique
FR2421181A1 (fr) Derives de substitution de spirooxazolidinone steroidienne, leur procede de preparation et compositions pharmaceutiques les contenant
FR2368490A1 (fr) Nouveaux derives de l'acide clavulanique, leur preparation et compositions pharmaceutiques en contenant